Emergent Biosolutions
EBS
EBS
238 hedge funds and large institutions have $1.88B invested in Emergent Biosolutions in 2017 Q4 according to their latest regulatory filings, with 52 funds opening new positions, 104 increasing their positions, 60 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
238
Holders Change
+40
Holders Change %
+20.2%
% of All Funds
5.41%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
%
% of All Funds
0.07%
New
52
Increased
104
Reduced
60
Closed
11
Calls
$684K
Puts
$1.29M
Net Calls
-$609K
Net Calls Change
-$1.63M
Top Buyers
| 1 |
Goldman Sachs
New York
|
$36.5M |
| 2 |
Renaissance Technologies
New York
|
$73.7M |
| 3 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
$16.4M |
| 4 |
O
OppenheimerFunds
New York
|
$15.4M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
$22.8M |
